Digital Solutions for bEtter cAre

The target population includes cancer patients, caregivers, family members, healthcare providers and mental health specialists, who will be the primary end-users of the Althea platform. For patients, survivors, caregivers, and family members, the sample variables include age, gender, type and stage of disease, and time since the first diagnosis. The healthcare professionals that will be involved in this study are those who attend to oncological patients, with sample variables such as age, gender, professional role, and prior experience and training in oncology or psycho-oncology.

NCT Number	NCT07416513
Lead Sponsor	European Institute of Oncology Collaborators: European Union
Conditions	Cancer Diagnosis
Enrollment	200 participants
Start Date	2025-05-14
Primary Completion	2026-12-31 (estimated)
Study Completion	2026-12-31 (estimated)
Updated on ClinicalTrials.gov	2026-02-18